CMPX FY 2022 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CMPXCompass Therapeutics, Inc.

$781M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$42M

Net Income

-$39M

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$200M

Total Liabilities

$18M

Stockholders' Equity

$182M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$42M	-$82M	+49.1%
Net Income	-$39M	-$82M	+52.3%